Regeneron Shares Drop Nearly 5%, Erasing $3.6 Billion in Market Value
As seen on the 24/7 Wall St. homepage on October 1, 2026.
A 4.89% slide to $729.05 takes roughly $3.6 billion off the biotech's market value in one session. Moves this size are rare for a $73.7 billion name, and the close is what matters now.
Continue ReadingShow less
Regeneron slid to a $729.05 close, a decline of nearly 5% in a single session that is historically unusual for a company of this size.
Roughly $3.6 billion in market value evaporated in one day, a loss large enough to force institutional holders to reassess position sizes and risk exposure, which extends selling pressure beyond the initial session.
Pressure ran from the open onward, with the stock finding no meaningful floor until the final stretch of trading. A brief bounce around midday faded quickly, and the stock drifted back near session lows to close at $729.05.
For investors already holding shares, the closing price is the number that counts, since it sets the baseline for any recovery or further deterioration when trading resumes. A move of this magnitude warrants close attention to whether volume and price action stabilize or continue to lean negative in the sessions ahead.
Sources
Mentioned: REGN